May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.
May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla, and hear him discuss the adoption of AI on the “In Good Company” podcast. Elsewhere on the leadership front, Chief Scientific Officer Chris Boshoff also recognized Pfizer’s research efforts for Clinical Trials Day, shared R&D highlights in Q1 2026, and emphasized the importance of staying alert for Lyme Disease Awareness month.
Get all the details of these updates and more:
Executive Leadership
- CEO Albert Bourla shares Pfizer’s first quarter results
- Chief Scientific Officer Chris Boshoff shares Pfizer’s R&D highlights for the first quarter
- CEO Albert Bourla sits down with Accenture CEO Julie Sweet to discuss the demands of leadership
- Chief Scientific Officer Chris Boshoff celebrates Pfizer’s research endeavors on Clinical Trials Day
- CEO Albert Bourla discusses the broader adoption of AI across Pfizer on “In Good Company”
- Chief U.S. Commercial Officer Aamir Malik highlights the importance of understanding the risks of Lyme disease for Lyme Disease Awareness month
- CEO Albert Bourla celebrates his passion for science and excitement for the future of innovation
Pfizer on LinkedIn
- Pfizer shares data across our work in cancer research for ASCO 2026
- Pfizer scientist, Shuo, shares her story in recognition of Cancer Research Month
- Pfizer shares how we’re working to bring science from the lab to life in our latest feature on TIME
- Pfizer’s treatment option for those living with hemophilia A or B with inhibitors has been approved by the European Medicines Agency
- Pfizer marks the opening of our new state-of-the-art Oncology R&D campus in San Diego, California
Pfizer on Instagram
- Pfizer extends our gratitude to those who make clinical research possible on Clinical Trials Day
- Pfizer colleague, Jennifer, shares the inspiration behind her work
Pfizer on X
Pfizer on TikTok
- Pfizer scientists share their thoughts on a skill every scientist should have
- Pfizer scientists share their favorite element
